Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) gapped up prior to trading on Monday following insider buying activity. The stock had previously closed at $36.45, but opened at $39.98.

Strategic Investment Report for TD Global Technology Leaders CAD Hedged Index ETF (TECX) Highlighting Buy and Sell Opportunities ...

Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) have been given an average recommendation of “Buy” by the six ...

Investment Strategy and Analysis for TD Global Technology Leaders CAD Hedged Index ETF (TECX) with Buy/Sell Signals ...

TIMOTHY A SPRINGER, a director at $TECX, bought 660,000 shares of the company on 02-05-2025 for an estimated $33,000,000. This trade was reported by Quiver ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Tectonic Therapeutic (TECX – Research Report), with a ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Tectonic Therapeutic (TECX – Research Report) today and set a price target of $76.00. The company’s shares closed yesterday at ...

WATERTOWN, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), today announced that it has entered into a securities purchase agreement for a ...